Cargando…
Efficacy and safety of oral palmitoleic acid supplementation for skin barrier improvement: A 12-week, randomized, double-blinded, placebo-controlled study
BACKGROUND: Palmitoleic acid (omega-7) has been reported to be effective primarily for metabolic disorders. Recently, it has been reported to help improve quality of life (QoL) by improving skin symptoms. OBJECTIVE: The aim of this randomized, double-blinded, placebo-controlled clinical study is to...
Autores principales: | Koh, Young Gue, Seok, Joon, Park, Jae Wan, Kim, Ka Ram, Yoo, Kwang Ho, Kim, Yong Joon, Kim, Beom Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245245/ https://www.ncbi.nlm.nih.gov/pubmed/37292315 http://dx.doi.org/10.1016/j.heliyon.2023.e16711 |
Ejemplares similares
-
Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
por: Koh, Young Gue, et al.
Publicado: (2023) -
Double bond configuration of palmitoleate is critical for atheroprotection
por: Cimen, Ismail, et al.
Publicado: (2019) -
Changes of Body Weight and Inflammatory Markers after 12-Week Intervention Trial: Results of a Double-Blind, Placebo-Control Pilot Study
por: Joo, Nam-Seok, et al.
Publicado: (2011) -
Efficacy of an Alpha-Blocker for the Treatment of Nonneurogenic Voiding Dysfunction in Women: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial
por: Lee, Young-Suk, et al.
Publicado: (2018) -
Intravenous Amantadine for Freezing of Gait Resistant to Dopaminergic Therapy: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Clinical Trial
por: Kim, Young Eun, et al.
Publicado: (2012)